Maureen D. Mayes

38.3k citations

227 papers · 14.3k indexed · 5 hit papers · h-index 62

Impact in

Pathology and Forensic Medicine top 0.02%
- Systemic Sclerosis and Related Diseases
Dermatology top 0.05%
- Dermatologic Treatments and Research

Papers in

Pathology and Forensic Medicine 202
- Systemic Sclerosis and Related Diseases 202
- Autoimmune Bullous Skin Diseases 15
Dermatology 58
- Dermatologic Treatments and Research 54

Co-authors: Shervin Assassi John D. Reveille Peter A. Merkel Frank C. Arnett Philip J. Clements James R. Seibold Daniel E. Furst Filemon K. Tan
Journals: Annals of the Rheumatic Diseases (24 papers)The Journal of Rheumatology (15 papers)Arthritis & Rheumatology (12 papers)Arthritis Care & Research (12 papers)Arthritis Research & Therapy (8 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Maureen D. Mayes

222 papers receiving 14.1k citations

Hit Papers

5 papers align trajectories log scale

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease 2019 · 956 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 New England Journal of Medicine
2017 Journal of Scleroderma and Related Disorders
2007 Arthritis & Rheumatism
2003 Arthritis & Rheumatism
1995 PubMed

Peers

Countries citing papers authored by Maureen D. Mayes

Since Specialization

Citations

This map shows the geographic impact of Maureen D. Mayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen D. Mayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen D. Mayes more than expected).

Fields of papers citing papers by Maureen D. Mayes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen D. Mayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen D. Mayes. The network helps show where Maureen D. Mayes may publish in the future.

Co-authors

The 25 scholars most cited alongside Maureen D. Mayes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maureen D. Mayes Line = papers co-authored together Maureen D. Mayes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ON RMD Open ·Yannick Allanore, Madelon C Vonk, Oliver Distler, Arata Azuma, Maureen D. Mayes, Alexandra James, Veronika Kohlbrenner, Margarida Alves, Dinesh Khanna, Kristin B. Highland	2025	1
2	Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long‐Term Normalization of Systemic Sclerosis Molecular Signatures Arthritis & Rheumatology ·Nancy Wareing, Xuan Wang, Lynette Keyes‐Elstein, Ellen Goldmuntz, Marka A. Lyons, Peter A. McSweeney, Daniel E. Furst, Richard A. Nash, Leslie J. Crofford, Beverly Welch, Ashley Pinckney, Maureen D. Mayes, Keith M. Sullivan, Shervin Assassi	2024	3
3	Exploring the complexity of systemic sclerosis etiology by trio whole genome sequencing Human Molecular Genetics ·Hongzheng Dai, Shamika Ketkar, Taotao Tan, Elizabeth G. Atkinson, Lindsay C. Burrage, Kim C. Worley, Brian Christopher, Marka A. Lyons, Shervin Assassi, Maureen D. Mayes, Brendan Lee	2024	1
4	Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10‐Item Connor‐Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study Arthritis Care & Research ·Marieke Alexandra Neyer, Richard S. Henry, Marie‐Eve Carrier, Linda Kwakkenbos, Robyn K. Wojeck, Amy Gietzen, Karen Gottesman, Geneviève Guillot, Amanda Lawrie‐Jones, Maureen D. Mayes, Luc Mouthon, Warren R. Nielson, Michelle Richard, Maureen Worron‐Sauvé, Daphna Harel, Vanessa L. Malcarne, Susan J. Bartlett, Brett D. Thombs, (unknown)	2023	5
5	Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis Annals of the Rheumatic Diseases ·Julia Z. Adamska, Amin Zia, Michelle S. Bloom, Leslie J. Crofford, Daniel E. Furst, Ellen Goldmuntz, Lynette Keyes-Elstein, Maureen D. Mayes, Peter A. McSweeney, Richard A. Nash, Ashley Pinckney, Beverly Welch, Zelda Z. Love, Keith M. Sullivan, William H. Robinson	2022	11
6	Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial Arthritis & Rheumatology ·Dinesh Khanna, Paul H. Caldron, Richard W. Martin, Suzanne Kafaja, Robert Spiera, Shadi Shahouri, Ankoor R. Shah, Vivien Hsu, John Ervin, Robert W. Simms, Robyn T. Domsic, Virginia Steen, Laura K. Hummers, Chris T. Derk, Maureen D. Mayes, Soumya Chatterjee, John Varga, Steven Kesten, John K. Fraser, Daniel E. Furst	2022	20
7	Genetic Associations of Non–Major Histocompatibility Complex Susceptibility Loci with Systemic Sclerosis in a Han Chinese Population Journal of Investigative Dermatology ·Weilin Pu, Rui Zhang, Yanyun Ma, Qingmei Liu, Shuai Jiang, Jing Liu, Yinhuan Zhao, Wenzhen Tu, Gang Guo, Xiaoxia Zuo, Qingwen Wang, Yuanyuan Chen, Wenyu Wu, Xiaodong Zhou, Jörg H. W. Distler, John D. Reveille, Hejian Zou, Jin Li, Maureen D. Mayes, Jiucun Wang	2021	1
8	Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis Arthritis & Rheumatology ·Robert Spiera, Laura K. Hummers, Leland W.K. Chung, Tracy Frech, Robyn T. Domsic, Vivien Hsu, Daniel E. Furst, Jessica Gordon, Maureen D. Mayes, Robert W. Simms, Robert Lafyatis, Viktor Martyanov, Tammara Wood, Michael L. Whitfield, S. Constantine, Elizabeth Lee, Nancy Dgetluck, Barbara White	2020	72
9	Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating ‘not applicable’ responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study BMJ Open ·Erin L. Merz, Linda Kwakkenbos, Marie-Eve Carrier, Shadi Gholizadeh, Sarah D. Mills, Rina S. Fox, Lisa R. Jewett, Heidi Williamson, Diana Harcourt, Shervin Assassi, Daniel E. Furst, Karen Gottesman, Maureen D. Mayes, Timothy Moss, Brett D. Thombs, Vanessa L. Malcarne	2018	8
10	Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases Annals of the Rheumatic Diseases ·Marialbert Acosta‐Herrera, Martin Kerick, David González‐Serna, Cisca Wijmenga, André Franke, Peter K. Gregersen, Leonid Padyukov, Jane Worthington, Timothy J. Vyse, Marta E. Alarcón‐Riquelme, Maureen D. Mayes, Javier Martı́n	2018	71
11	Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival. PubMed ·Michael Wodkowski, Marie Hudson, Susanna Proudman, Jennifer Walker, Wendy Stevens, Mandana Nikpour, Shervin Assassi, Maureen D. Mayes, Mianbo Wang, Murray Baron, Marvin J. Fritzler	2015	49
12	Determinants of Work Disability in Patients with Systemic Sclerosis: A Longitudinal Study of the GENISOS Cohort Seminars in Arthritis and Rheumatism ·Roozbeh Sharif, Maureen D. Mayes, Perry M. Nicassio, Emilio B. González, Hilda T. Draeger, Terry A. McNearney, Rosa M. Estrada‐Y‐Martin, Deepthi K. Nair, John D. Reveille, Frank C. Arnett, Shervin Assassi	2011	32
13	Identification of a novel HLA‐DPB1 allele, DPB1131:01, by sequence‐based typing Tissue Antigens* ·Constanza Rojo, J Tucker Charles, Nuong Thi Kieu Nguyen, John D. Reveille, Maureen D. Mayes	2011	3
14	Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls Annals of the Rheumatic Diseases ·F C Arnett, Pravitt Gourh, Sanjay Shete, Chul Ahn, Reddi Honey, Sandeep K. Agarwal, F K Tan, Terry A. McNearney, Michael A. Fischbach, Marvin J. Fritzler, Maureen D. Mayes, J. D. Reveille	2009	138
15	Scleroderma epidemiology Rheumatic Disease Clinics of North America ·Maureen D. Mayes	2003	170
16	Recombinant Human Relaxin in the Treatment of Scleroderma Annals of Internal Medicine ·James R. Seibold, Joseph H. Korn, Robert W. Simms, Phillip J. Clements, Larry W. Moreland, Maureen D. Mayes, Daniel E. Fürst, Naomi F. Rothfield, Virginia Steen, Michael Weisman, David H. Collier, Fredrick M. Wigley, Peter A. Merkel, Mary Ellen Csuka, Vivien Hsu, Susan Rocco, Mark Erikson, John H. Hannigan, W. Scott Harkonen, Martin E. Sanders	2000	44
17	Petroleum Distillate Solvents as Risk Factors for Undifferentiated Connective Tissue Disease (UCTD) American Journal of Epidemiology ·J. Lacey, David H. Garabrant, Timothy Laing, Brenda W. Gillespie, Maureen D. Mayes, B. C. Cooper, David Schottenfeld	1999	20
18	High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial Arthritis & Rheumatism ·Philip J. Clements, Daniel E. Fürst, Weng Kee Wong, Maureen D. Mayes, Barbara White, Fredrick M. Wigley, Michael H. Weisman, Walter G. Barr, Larry W. Moreland, Thomas A. Medsger, Virginia Steen, Richard W. Martin, David H. Collier, Arthur Weinstein, Edward V. Lally, John Varga, Steven Weiner, Brian S. Andrews, Micha Abeles, James R. Seibold	1999	210
19	Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma. PubMed ·Daniel O. Clegg, James C. Reading, Maureen D. Mayes, James R. Seibold, Cheryl P. Harris, Fredrick M. Wigley, John Ward, Edward J. Pisko, Michael H. Weisman, P. Lee, Larry W. Moreland, Rosemarie Neuner, Eric P. Gall, Philip J. Clements, Jason Spindler, Edward V. Lally	1994	13
20	Increased α‐Adrenergic responsiveness in idiopathic raynaud's disease Arthritis & Rheumatism ·Robert Freedman, Subhash C. Sabharwal, Nagaraj Desai, Paul Wenig, Maureen D. Mayes	1989	47

About Maureen D. Mayes

Maureen D. Mayes is a scholar working on Pathology and Forensic Medicine, Dermatology, Gastroenterology, Immunology and Rheumatology, having authored 227 papers that have together received 14.3k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (202 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (61 papers), Inflammatory Myopathies and Dermatomyositis (55 papers), Dermatologic Treatments and Research (54 papers), Mast cells and histamine (39 papers), Celiac Disease Research and Management (16 papers), Autoimmune Bullous Skin Diseases (15 papers) and Eosinophilic Disorders and Syndromes (11 papers). The work is most often cited by research in Pathology and Forensic Medicine (9.3k citations), Dermatology (3.2k citations), Rheumatology (3.2k citations), Immunology (3.2k citations) and Pulmonary and Respiratory Medicine (4.0k citations). Maureen D. Mayes has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Shervin Assassi, John D. Reveille, Peter A. Merkel, Frank C. Arnett, Philip J. Clements, James R. Seibold, Daniel E. Furst, Filemon K. Tan, Dinesh Khanna and Pravitt Gourh. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Arthritis & Rheumatology, Arthritis Care & Research and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact